background
neuroinflamm
play
critic
role
onset
develop
neurodegener
disord
parkinson
diseas
immun
activ
central
nervou
system
profoundli
affect
peripher
immun
activ
immun
toler
refer
unrespons
immun
system
continu
repeat
stimul
avoid
excess
inflamm
unnecessari
bystand
injuri
face
continu
antigen
threat
prove
immun
toler
could
suppress
develop
variou
peripher
inflammationrel
diseas
howev
role
immun
toler
neuroinflamm
neurodegen
diseas
clear
method
rat
inject
repeat
lowdos
lipopolysaccharid
lp
mgkg
intraperiton
day
induc
peripher
immun
toler
neuroinflamm
produc
use
intracrani
lp
inject
inflamm
cytokin
measur
use
enzymelink
immunosorb
assay
elisa
quantit
realtim
polymeras
chain
reaction
qrtpcr
microgli
activ
measur
use
immunostain
dopaminerg
neuron
damag
evalu
use
immunochemistri
stain
stereolog
count
thposit
neuron
behavior
impair
evalu
use
amphetamineinduc
rotat
behavior
assess
result
compar
nonimmun
toler
anim
pretreat
peripher
immun
toler
significantli
decreas
product
inflammatori
cytokin
suppress
microgli
activ
increas
number
dopaminerg
neuron
surviv
substantia
nigra
conclus
result
indic
peripher
immun
toler
attenu
neuroinflamm
inhibit
neuroinflammationinduc
dopaminerg
neuron
death
neuroinflamm
one
protuber
patholog
featur
neurodegen
diseas
includ
parkinson
diseas
pd
pd
character
dramat
loss
dopaminerg
da
neuron
substantia
nigra
sn
characterist
featur
neuroinflamm
includ
activ
glial
cell
seri
inflammatori
mediat
includ
proinflammatori
cytokin
chemokin
reactiv
oxygen
speci
nitric
oxid
element
prove
involv
develop
neuron
degener
despit
protect
bloodbrain
barrier
bbb
central
nervou
system
cn
could
deepli
affect
peripher
immun
well
establish
peripher
inflamm
give
rise
neuroinflamm
link
close
etiolog
progress
neurodegen
diseas
one
famou
studi
show
singl
intraperiton
ip
inject
lipopolysaccharid
lp
result
elev
product
proinflammatori
cytokin
delay
loss
dopaminerg
neuron
sn
hand
longterm
use
nonsteroid
antiinflammatori
drug
could
decreas
incid
pd
result
suggest
neuroinflamm
strongli
influenc
peripher
inflamm
microglia
vital
compon
brain
immun
system
play
crucial
role
maintain
brain
microenviron
homeostasi
activ
transform
rest
state
activ
state
chang
morpholog
prolifer
initi
inflammatori
respons
produc
proinflammatori
cytokin
neurotox
mediat
nitric
oxid
prostaglandin
reactiv
oxygen
speci
crosstalk
glial
cell
bbb
cell
neuron
studi
reveal
microgli
overactiv
caus
inflamm
may
disrupt
microenviron
brain
pose
threat
dopaminerg
neuron
surviv
monocyt
promot
organ
peripher
innat
immun
play
multipl
role
immun
system
recent
grow
bodi
research
concentr
role
monocyt
play
disord
cn
one
recent
studi
show
deplet
peripher
blood
monocyt
pbm
attenu
peripher
inflamm
also
neuroinflamm
induc
peripher
lp
inject
result
demonstr
monocyt
peripher
decis
element
process
neuroinflamm
induc
peripher
inflamm
moreov
monocyt
microglia
consid
share
origin
myeloid
lineag
mount
evid
reveal
monocyt
could
infiltr
brain
develop
microglia
construct
special
group
macrophag
find
impli
immun
respons
peripher
blood
monocyt
profound
signific
progress
prognosi
neuroinflamm
immun
toler
refer
refractori
immun
system
suffer
continu
antigen
threat
protect
mechan
bodi
suppress
peripher
immun
activ
order
avoid
excess
inflammatori
respons
unnecessari
bystand
injuri
endotox
toler
et
induc
low
dose
endotoxin
lipopolysaccharid
lp
deem
essenti
compon
immun
toler
remark
lp
peripher
precondit
prove
allevi
process
sever
neurolog
disord
middl
cerebr
arteri
occlus
syndrom
mcao
brain
trauma
brain
injuri
result
demonstr
import
role
immun
toler
play
neuroprotect
immun
toler
inhibit
peripher
immun
activ
reduc
subsequ
inflamm
howev
littl
known
role
neurodegen
diseas
propos
pretreat
induc
peripher
immun
toler
inhibit
intracrani
lp
injectioninduc
neuroinflamm
neurodegener
result
may
provid
novel
therapeut
strategi
treat
neuroinflammationrel
neurodegen
diseas
experi
conduct
male
spraguedawley
rat
week
old
g
anim
center
china
medic
univers
accord
nation
institut
health
guidelin
nation
institut
health
bethesda
usa
approv
ethic
committe
china
medic
univers
anim
unrestrict
access
food
water
hous
group
rat
per
cage
temperaturecontrol
environ
ambient
temperatur
lightdark
cycl
treatment
anim
number
acclim
week
afterward
rat
randomli
divid
follow
group
accord
random
number
gener
peripher
immun
toler
rat
given
pretreat
repeat
ip
inject
lp
mgkg
bodi
weightsingleday
day
varieti
concentr
explor
preliminari
experi
afterward
dose
lp
mgkg
determin
ultim
addit
file
figur
peripher
pretreat
rat
sacrif
peripher
blood
peripher
blood
monocyt
pbm
cultur
combin
densiti
gradient
centrifug
attach
cultur
method
cellsml
regard
appropri
cell
densiti
incub
co
adher
cell
growth
medium
chang
ngml
lp
given
pbm
vitro
h
order
mimic
subsequ
inflamm
test
immunolog
compet
pbm
level
proinflammatori
cytokin
supernat
measur
enzymelink
immunosorb
assay
elisa
also
express
tolllik
receptor
monocyt
measur
western
blot
stereotax
surgeri
rat
anesthet
ip
inject
chloral
hydrat
mgkg
afterward
place
stereotax
apparatu
skull
expos
dental
drill
use
make
small
hole
allow
striatal
inject
lp
ul
dissolv
pb
inject
unilater
follow
coordin
ap
mm
l
mm
v
mm
correspond
largest
segment
striatum
coron
plane
preliminari
experi
explor
lpsinduc
pd
rat
model
variou
stereotax
inject
site
variou
dose
lp
ultim
unilater
striatal
inject
lp
adopt
pd
model
present
studi
addit
file
figur
sham
group
inject
vehicl
pb
inject
control
rate
ulmin
hamilton
syring
needl
left
place
min
slowli
withdrawn
prevent
reflux
solut
rat
sacrif
day
final
treatment
right
sn
dissect
ice
tissu
homogen
ul
icecold
lysi
buffer
ml
ripa
lysi
buffer
pmsf
biyotim
shanghai
china
lyse
min
result
lysat
centrifug
g
see
figur
previou
page
fig
studi
procedur
group
first
part
experi
confirm
repeat
lowdos
lp
ip
inject
could
induc
immun
toler
pbm
without
inflamm
dopaminerg
neuron
loss
brain
induct
endotox
toler
rat
pretreat
repeat
mgkg
lp
intraperiton
inject
day
pbm
isol
cultur
restimul
higedos
lp
moreov
verifi
peripher
repeat
lowdos
lp
intraperiton
administr
fail
caus
inflamm
dopaminerg
neuron
loss
brain
parenchyma
rat
accord
differ
precondit
three
group
involv
control
group
n
pb
ip
group
n
lp
ip
group
n
second
part
experi
investig
neuroprotect
role
peripher
immun
toler
intracrani
lp
injectioninduc
neuroinflammationrel
neurodegener
neuroinflammationinduc
pd
rat
model
conduct
lp
intracrani
inject
right
striatum
inflammatori
cytokin
microgli
activ
loss
dopaminerg
neuron
well
behavior
impair
detect
indic
time
point
four
group
involv
includ
control
group
without
treatment
pb
striatum
group
striatal
pb
inject
sham
group
pb
ip
lp
striatum
group
peripher
pb
pretreat
prior
striatal
lp
inject
lp
ip
lp
striatum
group
peripher
lp
pretreat
prior
striatal
lp
inject
min
remov
particul
materi
centrifug
supernat
kept
use
analysi
afterward
protein
concentr
determin
use
bca
kit
biyotim
shanghai
china
enzym
analyz
equal
amount
protein
cell
lysat
tissu
lysat
separ
sdspage
gel
transfer
polyvinyliden
difluorid
pvdf
membran
biorad
california
usa
use
electrophoret
transfer
system
biorad
california
usa
block
fatfre
milk
room
temperatur
h
membran
incub
primari
antibodi
mous
antibodi
abcam
danver
usa
goat
antibodi
wako
tokyo
usa
mous
antibodi
gapdh
abcam
danver
usa
overnight
membran
rins
trisbuff
salin
contain
tween
tbst
time
min
per
time
incub
secondari
antibodi
horseradish
peroxidaselabel
antimous
igg
abcam
danver
usa
horseradish
peroxidaselabel
antigoat
igg
abcam
danver
usa
h
room
temperatur
follow
treatment
ecl
chemiluminesc
reagent
biorad
california
usa
expos
use
ecl
chemiluminesc
detector
biorad
california
usa
densiti
measur
band
perform
imagej
softwar
rel
level
normal
level
gapdh
express
graphic
rat
sacrif
right
sn
immedi
isol
total
rna
right
sn
extract
use
trizol
takara
dalian
china
accord
manufactur
instruct
quantifi
photometr
revers
transcript
perform
rt
reagent
kit
takara
dalian
china
quantit
realtim
pcr
qrtpcr
conduct
use
sybr
premix
ex
takara
dalian
china
light
cycler
ii
realtim
pcr
system
roch
diagnost
basel
switzerland
rel
express
among
group
calcul
use
method
primer
sequenc
list
follow
rat
gapdh
forward
gcagccca
gaacatcatcc
revers
gtcatcatacttggcag
gtt
rat
forward
actgaacttcggggtg
attg
revers
gtgggtgaggagcacgtagt
rat
forward
agctgcactgcaggcttcgagatg
revers
gaactgtgcagactcaaactccac
rat
forward
tgaggttccctgtgtgtctg
revers
ggttgtaggtgtctccgtgaa
rat
th
forward
ctactgtccgcccgtgattt
revers
caca
ggctggtaggtttgatc
day
post
striatal
inject
rat
deepli
anesthet
perfus
aorta
salin
follow
paraformaldehyd
dissolv
pb
ph
brain
dissect
fix
buffer
paraformaldehyd
cryoprotect
sucros
solut
day
coron
serial
section
um
throughout
sn
cut
use
freez
microtom
leica
germani
maintain
afterward
section
store
glycerinum
histolog
analysi
brain
section
rins
pb
pretreat
h
min
inhibit
endogen
peroxidas
activ
rins
pb
time
min
per
time
section
block
bovin
serum
albumin
bsa
min
room
temperatur
section
incub
overnight
follow
primari
antibodi
mous
antibodi
abcam
danver
usa
goat
antibodi
tyrosin
hydroxylas
th
abcam
danver
usa
goat
antibodi
wako
tokyo
usa
section
wash
pb
post
incub
fluoresc
stain
section
incub
alexa
fluor
secondari
antibodi
molecular
probe
california
usa
h
room
temperatur
besid
hoechst
biyotim
shanghai
china
use
label
cell
nucleu
immunostain
section
evalu
use
fluoresc
microscop
olympu
tokyo
japan
histochemistri
stain
section
incub
biotinyl
rabbitantigoat
secondari
antibodi
min
incub
primari
antibodi
follow
incub
avidinconjug
horseradish
peroxidas
min
dab
use
develop
color
section
dehydr
use
alcohol
gradient
clear
xylen
cover
slip
neutral
gum
microscop
analysi
evalu
loss
dopaminerg
neuron
unbias
stereolog
count
thposit
neuron
made
use
optic
fraction
method
perform
olympu
comput
assist
stereolog
toolbox
system
version
olympu
ballerup
denmark
sampl
techniqu
previous
describ
detail
modif
unaffect
volum
refer
size
count
element
coron
serial
section
use
count
cover
entir
sn
rostral
tip
par
compacta
ap
mm
back
caudal
end
par
reticul
ap
mm
gener
yield
section
rat
estim
total
number
thposit
neuron
sn
everi
sixth
section
count
moreov
count
frame
grid
size
use
guard
volum
top
bottom
section
exclud
surfac
avoid
problem
lost
cap
profil
came
focu
within
count
volum
depth
count
estim
total
number
thposit
neuron
calcul
accord
optic
fraction
formula
day
test
amphetamineinduc
rotat
behavior
carri
test
rat
place
hemispher
bowl
immedi
receiv
mgkg
amphetamin
dissolv
normal
salin
sigma
st
loui
usa
ip
inject
number
ipsilater
measur
everi
minut
min
per
rat
data
present
mean
standard
error
mean
sem
test
varianc
homogen
normal
distribut
perform
ensur
assumpt
requir
standard
parametr
analysi
varianc
satisfi
homogen
varianc
equal
oneway
analysi
varianc
anova
follow
least
signific
digit
lsd
test
use
assumpt
homogen
varianc
met
welch
test
appli
dunnett
test
use
comparison
pairwis
signific
data
analyz
use
spss
p
valu
less
consid
statist
signific
test
whether
endotox
toler
could
induc
repeat
lowdos
lp
intraperiton
inject
secret
pbm
express
pbm
quantifi
post
singledos
lp
ngml
administr
pb
ip
group
receiv
repeat
intraperiton
inject
pb
prior
singl
high
dose
lp
administr
amount
supernat
increas
moreov
express
also
upregul
compar
control
group
without
lp
restimul
shown
fig
compar
pb
ip
group
signific
decreas
level
p
p
observ
lp
ip
group
caus
repeat
mgkg
lp
intraperiton
inject
besid
express
upregul
p
lp
ip
group
control
fig
repeat
lowdos
lp
intraperiton
injectioninduc
endotox
toler
pbm
pbm
three
group
without
lp
pretreat
vivo
isol
cultur
secret
pbm
express
pbm
quantifi
post
singl
highdos
lp
ngml
administr
h
vitro
product
decreas
express
pbm
downregul
lp
restimul
repeat
mgkg
lp
intraperiton
inject
lp
ip
group
b
level
b
supernat
detect
elisa
c
express
pbm
quantifi
measur
band
intens
use
imagej
softwar
valu
normal
gapdh
p
p
vs
control
group
p
p
vs
pb
ip
group
data
present
mean
sem
n
group
still
downregul
p
compar
pb
ip
group
result
demonstr
endotox
toler
pbm
could
induc
repeat
lowdos
lp
intraperiton
inject
rat
verifi
pretreat
repeat
lowdos
lp
intraperiton
inject
suffici
caus
inflamm
sn
investig
level
preinflammatori
cytokin
express
right
sn
rat
lp
ip
group
day
post
last
peripher
lp
inject
show
fig
signific
differ
control
group
time
point
lp
ip
group
neither
amount
fig
fig
express
fig
timedepend
effect
exist
either
result
indic
repeat
lowdos
lp
intraperiton
inject
suffici
caus
inflamm
sn
rat
confirm
pretreat
repeat
lowdos
lp
intraperiton
inject
suffici
caus
dopaminerg
neuron
loss
sn
carri
immunohistochem
stain
th
stereolog
count
thposit
neuron
nonintracrani
inject
sn
rat
lp
ip
group
day
post
last
peripher
lp
inject
show
fig
dopaminerg
neuron
morpholog
fig
total
number
thposit
cell
fig
express
signific
differ
control
group
time
point
lp
ip
group
result
indic
repeat
lowdos
lp
intraperiton
inject
suffici
caus
dopaminerg
neuron
loss
sn
rat
test
whether
peripher
immun
toler
precondit
abl
prevent
intracrani
lp
injectioninduc
neuroinflamm
first
investig
express
proinflammatori
cytokin
right
sn
elisa
striatal
lp
administr
caus
timedepend
increas
express
sn
group
without
peripher
lp
precondit
fig
compar
pb
ip
lp
striatum
group
endotox
toler
pretreat
significantli
decreas
express
fig
repeat
lowdos
lp
intraperiton
inject
precondit
caus
inflamm
sn
investig
level
proinflammatori
cytokin
express
right
sn
rat
day
post
peripher
lp
inject
signific
differ
control
group
time
point
lp
ip
group
amount
express
b
level
b
right
sn
detect
elisa
c
express
right
sn
quantifi
measur
band
intens
use
imagej
softwar
valu
normal
gapdh
data
present
mean
sem
n
fig
well
decreas
express
day
individu
post
striatal
lp
inject
fig
examin
express
profil
right
sn
qrtpcr
signific
decreas
mrna
level
observ
lp
ip
lp
striatum
group
compar
pb
ip
lp
striatum
group
indic
time
point
fig
lp
ip
lp
striatum
group
show
signific
decreas
mrna
level
day
fig
well
decreas
mrna
level
day
fig
result
show
peripher
immun
toler
precondit
decreas
intracrani
lp
injectioninduc
proinflammatori
cytokin
sn
test
whether
peripher
immun
toler
precondit
abl
prevent
intracrani
lp
injectioninduc
increas
antiinflammatori
factor
measur
express
antiinflammatori
cytokin
right
sn
elisa
level
increas
last
least
day
striatal
lp
inject
group
without
peripher
lp
precondit
fig
howev
endotox
toler
pretreat
made
signific
increas
day
post
striatal
lp
exposur
fig
furthermor
signific
differ
express
lp
ip
lp
striatum
group
pb
ip
lp
striatum
group
time
point
observ
fig
striatal
vehicl
inject
pb
ip
group
made
differ
amount
antiinflammatori
cytokin
compar
control
group
result
suggest
peripher
immun
toler
precondit
alter
intracrani
lp
injectioninduc
antiinflammatori
cytokin
sn
firstli
observ
morpholog
chang
microglia
use
immumohistochem
stain
show
fig
microglia
control
group
rest
form
character
small
soma
thin
process
well
small
cellular
count
fig
day
post
lp
exposur
amoeboid
microglia
observ
right
sn
fig
microglia
typic
activ
form
character
enlarg
soma
thicken
process
day
post
lp
administr
fig
f
howev
endotox
toler
precondit
still
result
fewer
microgli
count
lighter
immunohistochem
stain
fig
microglia
lp
ip
lp
striatum
group
almost
return
rest
state
day
fig
microglia
pb
ip
lp
striatum
group
still
show
deeper
immunohistochem
stain
fig
compar
control
group
striatal
vehicl
inject
pb
ip
group
alter
microgli
morpholog
fig
compar
control
group
nextli
measur
express
sn
immunofluoresc
assay
shown
fig
compar
control
group
two
group
receiv
intracrani
lp
inject
show
timedepend
enhanc
fluoresc
intens
post
striatal
lp
exposur
compar
pb
ip
lp
striatum
group
pretreat
endotox
toler
decreas
fluoresc
intens
fig
decreas
fluoresc
intens
present
two
group
day
furthermor
peripher
lp
pretreat
reduc
fluoresc
intens
fig
moreov
fluoresc
intens
lp
ip
lp
striatum
group
mainli
return
normal
state
day
still
time
higher
pb
ip
lp
striatum
group
control
group
peripher
immun
toler
precondit
decreas
intracrani
lp
injectioninduc
product
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
right
sn
dissect
time
point
day
striatal
lp
inject
elisa
analysi
result
show
product
decreas
peripher
lp
precondit
day
intracrani
lp
exposur
af
express
ac
df
right
sn
detect
elisa
day
differ
impercept
day
data
shown
p
p
vs
control
group
p
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
n
express
profil
right
sn
detect
qrtpcr
mrna
level
show
timedepend
increas
two
group
receiv
intracrani
lp
inject
maximum
day
minimum
day
post
striatal
lp
administr
fig
addit
pretreat
endotox
toler
decreas
mrna
level
day
p
fig
day
p
fig
significantli
alter
express
profil
day
fig
striatal
vehicl
inject
pb
ip
group
made
differ
express
compar
control
group
result
show
endotoxin
toler
precondit
inhibit
intracrani
lp
injectioninduc
microgli
activ
sn
peripher
immun
toler
pretreat
pd
rat
show
decreas
intracrani
lp
injectioninduc
dopaminerg
neuron
loss
sn
unilater
striatal
inject
lp
made
progress
signific
loss
thposit
neuron
day
day
striatal
lp
exposur
howev
differ
detect
day
compar
group
receiv
striatal
pb
exposur
addit
file
figur
probe
whether
endotox
toler
pretreat
pd
rat
could
decreas
neuroinflammationinduc
dopaminerg
neuron
loss
carri
immunohistochem
stain
th
stereolog
count
thposit
neuron
sn
show
fig
striatal
lp
inject
decreas
total
number
thposit
neuron
time
two
group
howev
reduct
rapid
sever
group
without
endotox
toler
precondit
peripher
lp
precondit
made
increas
total
number
thposit
neuron
fig
moreov
neuroprotect
becam
promin
day
increas
fig
express
profil
th
right
sn
detect
qrtpcr
th
mrna
level
pb
ip
lp
striatum
group
show
obviou
decreas
time
lp
ip
lp
striatum
group
control
fig
day
th
mrna
level
two
group
receiv
striatal
lp
administr
time
control
group
fig
reveal
endotox
toler
pretreat
upregul
th
mrna
level
p
moreov
differ
becam
obviou
day
fig
differ
shown
day
fig
b
striatal
vehicl
inject
pb
ip
group
made
differ
th
express
compar
control
group
result
underlin
endotox
toler
pretreat
could
decreas
intracrani
lp
injectioninduc
dopaminerg
neuron
loss
test
amphetamineinduc
rotat
behavior
perform
day
post
striatal
lp
inject
assess
behavior
impair
shown
fig
striatal
lp
inject
caus
mark
ipsilater
rotat
behavior
toward
lesion
side
pb
ip
lp
striatum
group
notic
decreas
p
ipsilater
turn
develop
peripher
lp
pretreat
compar
pb
ip
pb
striatum
group
striatal
vehicl
inject
pb
ip
group
made
differ
behavior
chang
least
day
compar
control
group
result
clarifi
endotox
toler
pretreat
could
improv
intracrani
lp
injectioninduc
behavior
impair
neuroinflamm
establish
crucial
mechan
neurodegener
moreov
grow
bodi
evid
demonstr
peripheri
immun
exert
signific
impact
neuroinflamm
recent
studi
identifi
key
role
pbm
microglia
inflammatori
transmiss
fig
peripher
immun
toler
precondit
alter
intracrani
lp
injectioninduc
product
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
right
sn
dissect
time
point
day
striatal
lp
inject
elisa
analysi
result
indic
product
increas
day
intracrani
lp
exposur
differ
observ
time
point
well
time
point
pb
ip
lp
striatum
group
lp
ip
lp
striatum
group
af
express
ac
df
right
sn
detect
elisa
p
p
p
vs
control
group
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
n
peripheri
brain
demonstr
strong
influenc
flame
peripher
inflamm
brain
immun
reactiv
immun
toler
restrict
excess
inflamm
serv
vital
mechan
avoid
unnecessari
bystand
injuri
monocytemacrophag
serv
main
cell
respons
induct
immun
toler
vivo
investig
effect
peripher
immun
toler
pretreat
neuroinflammationinduc
neurodegener
peripher
immun
toler
suppress
inflammatori
activ
peripher
blood
monocyt
immun
toler
protect
mechan
face
excess
inflamm
unnecessari
bystand
injuri
endotox
toler
alway
induc
low
dose
lp
deem
essenti
compon
immun
toler
suffer
subsequ
inflammatori
challeng
studi
indic
repeat
intraperiton
inject
mgkg
lp
consecut
day
inde
induc
fig
intracrani
lp
injectioninduc
microgli
activ
inhibit
peripher
immun
toler
precondit
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
brain
remov
day
striatal
inject
result
display
peripher
immun
toler
pretreat
reliev
intracrani
lp
injectioninduc
microgli
activ
decreas
fluoresc
intens
immunofluoresc
stain
frozen
section
red
hoechst
blue
four
group
observ
sinc
control
group
pb
striatum
group
statist
signific
time
point
select
day
repres
bd
bar
chart
display
fluoresc
intens
n
group
p
vs
control
group
p
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
scale
bar
endotox
toler
pbm
character
decreas
proinflammatori
cytokin
downregul
express
lp
restimul
decreas
inflammatori
cytokin
show
peripher
immun
toler
inducedhypoact
state
pbm
serv
major
pattern
recognit
receptor
involv
detect
lp
downregul
express
mean
diminish
inflammatori
respons
pbm
prove
pbm
decis
cell
format
lpsinduc
peripher
immun
toler
previou
studi
prove
peripher
highdos
lp
mgkg
inject
could
induc
inflammatori
effect
sn
demonstr
increas
proinflammatori
cytokin
microgli
activ
line
classic
studi
carri
qin
et
al
howev
dose
lp
use
present
studi
consid
lowdos
mgkg
intracephal
immun
statu
monitor
repeat
lowdos
lp
injectioninduc
peripher
immun
toler
result
indic
repeat
lowdos
lp
intraperiton
inject
insuffici
caus
inflamm
within
sn
healthi
rat
neither
increas
inflammatori
cytokin
upregul
previou
studi
demonstr
level
distribut
inflammatori
factor
brain
vari
variou
dosag
peripher
lp
administr
quan
et
al
confirm
high
dose
lp
induc
global
express
proinflammatori
cytokin
brain
wherea
low
dose
lp
increas
mrna
express
choroid
plexu
circumventricular
organ
mening
without
brain
parenchyma
conclus
coincid
result
although
region
outsid
sn
measur
studi
addit
also
observ
neuron
morpholog
total
number
dopaminerg
neuron
sn
repeat
intraperiton
lp
administr
result
reveal
immunoreact
th
express
dopaminerg
neuron
preserv
sn
present
studi
investig
role
peripher
immun
toler
occurr
progress
subsequ
intracrani
lp
injectionneuroinflamm
result
show
peripher
immun
toler
precondit
attenu
intracrani
lp
injectioninduc
neuroinflamm
manifest
decreas
inflammatori
cytokin
inhibit
microgli
activ
suggest
regul
pbm
immun
statu
could
affect
progress
neuroinflamm
specul
neuroinflammatori
allevi
induc
peripher
immun
toler
precondit
follow
way
monocyt
microglia
consid
share
origin
myeloid
lineag
thu
immun
toler
pretreat
induc
hyporespons
monocyt
may
reflect
weaken
immun
activ
microglia
brain
correspondingli
b
immun
toler
pbm
may
decreas
proinflammatori
cytokin
infiltr
peripheri
brain
correspondingli
c
peripher
immun
toler
may
impair
immun
activ
pbm
would
migrat
peripheri
brain
fig
intracrani
lp
injectioninduc
microgli
activ
inhibit
peripher
immun
toler
precondit
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
brain
remov
day
striatal
inject
result
display
peripher
immun
toler
pretreat
reliev
intracrani
lp
injectioninduc
microgli
activ
downregul
mrna
level
ac
mrna
level
quantifi
qrtpcr
n
group
p
p
vs
control
group
p
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
develop
microglia
directli
interact
microglia
indirectli
aggrav
neuron
damag
neuroinflamm
peripher
immun
toler
may
reshap
central
microenviron
neuroinflamm
challeng
lessen
interact
pbm
cell
brain
perivascular
cell
well
endotheli
cell
bbb
e
hyporeact
pbm
induc
peripher
immun
toler
may
associ
reduc
cellular
infiltr
brain
peripher
immun
toler
pretreat
protect
rat
neuroinflammationinduc
neurodegener
incid
peripher
immun
toler
report
sever
system
diseas
set
includ
sepsi
trauma
surgeri
pancreat
underlin
clinic
signific
studi
evalu
effect
peripher
immun
toler
neuroinflammationrel
neurodegener
result
suggest
lp
precondit
could
protect
rat
neuroinflammationinduc
neurodegener
show
increas
neuron
surviv
improv
behavior
damag
rosenzweig
et
al
clarifi
lp
precondit
modul
cellular
inflammatori
respons
cerebr
ischemia
result
neuroprotect
besid
lp
precondit
confer
neuroprotect
prove
traumat
brain
injuri
deep
hypotherm
circulatori
arrest
accord
result
observ
peripher
immun
toler
preconditioninginduc
hyporespons
pbm
led
signific
neuroprotect
subsequ
neurodegener
suffici
show
pbm
serv
signific
regul
develop
progress
neurodegen
diseas
recogn
excess
microgli
activ
lead
develop
neurodegen
diseas
contrari
present
studi
show
neuroprotect
lp
precondit
neurodegener
accompani
inhibit
microgli
activ
rodent
pretreat
fluoxetin
somatostatin
show
neuroprotect
effect
depend
inhibit
neuroinflammationrel
microgli
see
figur
previou
page
fig
peripher
immun
toler
pretreat
pd
rat
protect
intracrani
lp
injectioninduc
neurodegener
increas
dopaminerg
neuron
surviv
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
brain
remov
day
striatal
inject
result
impli
peripher
immun
toler
pretreat
protect
pd
rat
neuroinflammationrel
neurodegener
increas
dopaminerg
neuron
surviv
immunohistochemistri
stain
frozen
section
th
four
group
observ
sinc
control
group
pb
striatum
group
statist
signific
time
point
select
day
repres
moreov
differ
distinguish
earli
day
data
pb
ip
lp
striatum
group
lp
ip
lp
striatum
group
day
shown
bd
total
number
thposit
neuron
inject
side
sn
right
sn
collect
stereolog
count
n
group
p
p
p
vs
control
group
p
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
scale
bar
fig
peripher
immun
toler
pretreat
pd
rat
protect
intracrani
lp
injectioninduc
neurodegener
increas
dopaminerg
neuron
surviv
sn
rat
four
group
without
peripher
lp
pretreat
sacrif
brain
remov
day
striatal
inject
result
impli
peripher
immun
toler
pretreat
protect
pd
rat
neuroinflammationrel
neurodegener
upregul
mrna
level
th
ac
mrna
level
th
quantifi
qrtpcr
n
group
p
p
vs
control
group
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
activ
result
highlight
neuroprotect
role
microgli
immunocompet
restrict
neuroinflammationinduc
neurodegen
diseas
therefor
inhibit
microgli
overactiv
caus
peripher
immun
toler
produc
neuroprotect
taken
togeth
studi
provid
evid
peripher
immun
toler
precondit
play
crucial
role
neuroprotect
subsequ
neuroinflammationinduc
neurodegener
pbm
microglia
may
serv
potenti
signific
element
neuroprotect
differ
previou
studi
regard
neurodegener
system
diseas
rather
disord
limit
cn
result
studi
may
provid
evid
immunolog
commun
brain
peripheri
like
produc
easier
conveni
peripher
way
manipul
immunolog
activ
within
brain
howev
studi
limit
studi
molecular
mechan
signal
pathway
neuroprotect
need
implement
peripher
immun
toler
import
regulatori
mechan
immunolog
activ
pbm
result
strongli
indic
peripher
immun
toler
attenu
subsequ
neuroinflamm
provid
neuroprotect
neuroinflammationinduc
neurotox
provid
new
therapeut
approach
neurodegen
diseas
addit
file
figur
repeat
intraperiton
inject
mgkg
lp
day
induc
peripher
immun
toler
pbm
peripher
blood
monocyt
rat
five
group
pretreat
pb
mlkg
lp
mgkg
without
pretreat
control
group
isol
cultur
monocyt
restimul
singl
highdos
lp
ng
h
vitro
product
express
pbm
downregul
lp
restimul
repeat
mgkg
lp
intraperiton
inject
mgkg
lp
ip
group
similar
downregul
inflamm
observ
two
group
repeat
mgkg
lp
intraperiton
inject
ab
level
b
supernat
detect
elisa
cd
product
pbm
quantifi
measur
band
intens
use
imagej
softwar
valu
normal
gapdh
p
p
vs
control
group
p
p
p
vs
pb
ip
group
data
present
mean
sem
n
tiff
kb
addit
file
figur
striatal
inject
lpsinduc
gener
loss
dopaminerg
neuron
sn
singl
dose
vehicl
pb
lp
pb
administ
right
striatum
pb
striatum
group
lp
striatum
group
individu
control
group
without
treatment
brain
remov
time
point
day
striatal
inject
right
sn
dissect
result
impli
striatal
inject
lp
induc
signific
loss
dopaminerg
neuron
sn
immunohistochemistri
stain
frozen
section
th
three
group
observ
sinc
control
group
pb
striatum
group
statist
signific
time
point
select
control
group
repres
moreov
differ
distinguish
earli
day
data
pb
striatum
group
lp
striatum
group
day
shown
peripher
immun
toler
pretreat
pd
rat
protect
intracrani
lp
injectioninduc
neurodegener
improv
behavior
impair
rat
control
group
pb
striatum
group
pb
ip
lp
striatum
group
lp
ip
lp
striatum
group
administr
singl
dose
amphetamin
mgkg
day
post
intracrani
inject
number
ipsilater
turn
record
min
result
show
allevi
behavior
impair
caus
peripher
lp
pretreat
number
ipsilater
turn
per
minut
min
amphetamin
inject
b
total
number
ipsilater
turn
within
min
amphetamin
inject
p
vs
control
group
p
vs
pb
ip
lp
striatum
group
data
present
mean
sem
n
